The Antinuclear Antibody (ANA) Test Market is undergoing significant transformation as global healthcare systems intensify their focus on early detection and management of autoimmune diseases. ANA testing remains a foundational diagnostic tool for identifying conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren’s syndrome. Within this rapidly...